Good morning :)
Place Order
Add to Watchlist
Home
Portfolio
Search
digi goldGold
More

Bharat Immunologicals and Biologicals Corporation Ltd

BIBCL

Bharat Immunologicals and Biologicals Corporation Ltd

BIBCL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹114 cr, stock is ranked 2,402
High RiskStock is 5.56x as volatile as Nifty
26.650.87% (+0.23)
26.650.87% (+0.23)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹114 cr, stock is ranked 2,402
High RiskStock is 5.56x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹114 cr, stock is ranked 2,402
High RiskStock is 5.56x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-6.321.30—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
43.705.020.72%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bharat Immunologicals and Biologicals Corporation Limited is a biotechnology company that manufactures and produces a range of pharmaceuticals products.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 5.55%, vs industry avg of 8.45%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.02% to 0.01%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue146.95129.42125.3736.1987.8768.0287.0179.4947.418.51
Raw Materialssubtract114.44112.9370.7226.9792.7974.3067.7464.9335.7125.40
Power & Fuel Costsubtract2.212.231.661.241.741.851.551.691.35
Employee Costsubtract9.6110.0310.2110.319.7811.3714.4413.8515.32
Selling & Administrative Expensessubtract2.202.428.810.960.450.650.600.731.05
Operating & Other expensessubtract14.354.4419.963.24-11.79-10.9421.872.169.64
Depreciation/Amortizationsubtract0.910.650.580.410.280.240.240.210.150.19
Interest & Other Itemssubtract1.135.694.211.012.004.754.795.607.057.54
Taxes & Other Itemssubtract0.55-2.752.71-3.70-1.58-3.99-6.10-0.93-5.79-6.56
EPS0.36-1.441.51-0.98-1.34-2.36-4.20-2.03-3.95-4.18
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bharat Immunologicals and Biologicals Corporation Ltd-6.681.30—
Sun Pharmaceutical Industries Ltd34.044.860.96%
Cipla Ltd34.624.090.71%
Dr Reddy's Laboratories Ltd21.114.090.70%

Price Comparison

Compare BIBCL with any stock or ETF
Compare BIBCL with any stock or ETF
BIBCL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding59.25%0.00%0.00%0.00%40.75%

Dec 2022

Mar 2023

Jun 2023

Sep 2023

Shareholding History

JunSepDec '22MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BIBCL has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time

News & Opinions

Hmm, looks like data is unavailable here. Please come back after some time.